| __timestamp | Protagonist Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 31354781 |
| Thursday, January 1, 2015 | 11831000 | 43445817 |
| Friday, January 1, 2016 | 25705000 | 66489820 |
| Sunday, January 1, 2017 | 46181000 | 96886134 |
| Monday, January 1, 2018 | 59497000 | 153793000 |
| Tuesday, January 1, 2019 | 65003000 | 148369000 |
| Wednesday, January 1, 2020 | 74506000 | 151934000 |
| Friday, January 1, 2021 | 126006000 | 198532000 |
| Saturday, January 1, 2022 | 126215000 | 112128000 |
| Sunday, January 1, 2023 | 120161000 | 76192000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Protagonist Therapeutics, Inc. have been at the forefront of this race. From 2014 to 2023, TG Therapeutics consistently outpaced Protagonist Therapeutics in R&D investment, peaking in 2021 with a staggering 198% increase from its 2014 levels. However, Protagonist Therapeutics showed remarkable growth, with its R&D spending increasing by over 1,500% during the same period. Notably, in 2022, Protagonist Therapeutics surpassed TG Therapeutics, marking a pivotal shift in their R&D strategies. This trend highlights the dynamic nature of the biotech industry, where strategic investments can redefine market positions. As these companies continue to innovate, their R&D spending will be a critical factor in shaping their future success.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending